API
![Potassium e hloekileng (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl) amino]phenylacetate ka theko e ntle](https://ecdn6.globalso.com/upload/p/689/image_product/2024-04/661cf240b167b43209.png)
Moetsi oa bohloeki bo phahameng CAS 1197-18-8 Tranexamic Acid
Tranexamic acid, eo hape e bitsoang tranexamic acid, ke motsoako oa maiketsetso oa lysine o nang le sebopeho se tšoanang le sa tyrosine. E netefalitsoe ke liteko tsa kliniki, e loketse mefuta eohle ea letlalo 'me e ka tlosa mebala, ho soeufatsa, le matheba a bobebe, joalo ka: ho hlahisa mebala ka mor'a ho pepesehela letsatsi, matheba a lefifi (chloasma, freckles, senile lentils, joalo-joalo), letlalo le bonolo, makhopho le ho ruruha, ka mor'a ts'ebetso ea tlhokomelo ka mor'a laser, phekolo ea pulsed light, joalo-joalo Ka hona, tranexamic acid e ka buelloa hore e sebelisoe litlolo tse kang litlolo, litlolo, li-essence, lotions, le mask a sefahleho.
Tranexamic acid ke sethethefatsi sa maiketsetso sa amino acid sa antifibrinolytic se ka thibelang ka tlholisano ho tlama ha lysine ho fibrin ho plasmin, ka tsela eo ho thibela lysis ea maqeba a fibrin le ho hlahisa hemostasis. E sebelisoa haholo-holo kliniki. Bakeng sa mefuta e sa tšoaneng ea mali a bakoang ke hyperfibrinolysis.
Lisebelisoa tsa Tranexamic acid
1. Tranexamic acid ke sethethefatsi se khahlanong le fibrinolytic, se ka tšoara mali a fapaneng a hlobaetsang le a sa foleng le ho fihlela hemostasis.
2.Tranexamic acid e ka fokotsa tlhahiso ea melanin: E ka hlōlisana ka ho toba le tyrosine liseleng, e thibela phello ea catalytic ea tyrosine metabolism, le ho fokotsa tlhahiso ea melanin.
3. Thibela angiogenesis: E ka hlōlisana ka ho toba le tyrosine liseleng, ea thibela phello ea catalytic ea tyrosine metabolism, 'me ea thibela angiogenesis ea letlalo. Sena se ka fokotsa palo ea methapo ea mali kahare le haufi le liso tsa chloasma, sa fokotsa ho hlaha ha maikutlo a ho ruruha, 'me ka hona sa fokotsa sebopeho se tsoelang pele sa chloasma.
4.Tranexamic acid e ka fokotsa polelo ea li-cytokine tsa pro-inflammatory le li-chemokine ho sebelisa liphello tse khahlanong le ho ruruha, tse ka thibelang ka katleho ho etsahala ha liphello tsa ho kula le ho fokotsa ho thehoa ha li-acne.
5. Asiti ea Tranexamic e na le lintho tse khahlanong le botsofali le li-anti-photoaging. E ntlafatsa motsoako oa hyaluronic acid ka ho eketsa palo ea lisele tsa epidermal, e fokotsa ho senyeha ha matrix a extracellular ka dermis ka ho thibela plasmin, 'me e ka fokotsa maemo a lintho tse ling tsa oxidative maling ho ntlafatsa botsofali ba tlhaho ba letlalo. E ntlafatsa ho etsa lifoto tsa UVB ka ho eketsa biogenesis ea mitochondrial, ho laola secretion ea li-hormone ka ho eketsa polelo ea li-receptor tsa estrogen holim'a lisele tsa mast, le ho ntlafatsa ho etsa lifoto tse entsoeng ke UVA.
Tlhaloso ea Tranexamic acid
Hebei WeiBang Biotechnology Co., Ltd
| Lebitso la Sehlahiswa | Tranexamic acid | Nomoro ea CAS | 1197-18-8 |
| Letsatsi la Tlhahiso | 2023/12/01 | Letsatsi la Tlaleho | 2023/12/01 |
| Bongata | 10,000KG | Letsatsi la Teko | 2023/12/01 |
| BatchNo | WB20231201 | Shelf bophelo | lilemo tse 2 |
| Lintho tsa ho Leka | Tlhaloso | ||
| Ponahalo | Phofo e tšoeu ea kristale | ||
| Boitsebiso | LE | ||
| Tahlehelo ka ho omisa | ≤0.50% | ||
| pH | 7.0-8.0 | ||
| Tlhahlobo | ≥99.0 | ||
| Molora o nang le sulphated | ≤0.10% | ||
| Ntho e amanang le yona | Tšilafalo A: ≤0.10% | ||
| Tšilafalo B: ≤0.20% | |||
| Tšilafalo efe kapa efe: ≤0.10% | |||
| Litšila tse ling kaofela: ≤0.20% | |||
| Li-chloride | ≤140ppm | ||
| Kakaretso ea palo ea lipoleiti | ≤1000cfu/g | ||
| Tomoso & hlobo | ≤100cfu/g | ||
| Pb | ≤10mg/kg | ||
| Joalo ka | ≤2mg/kg | ||
| Hg | ≤1mg/kg | ||
| Cd | ≤5mg/kg | ||
| Qetello | Ea tšoanelehang | ||